Wright Therapy receives $4.4M boost from investors | Equity round brings in $3M for ForSight Vision6 | K2M Group plans to move headquarters to Va.
Web Version

December 15, 2014
ADVAMED SmartBrief
News for medical technology professionals

Top Story
Wright Therapy receives $4.4M boost from investors
A group of investors has pumped about $4.4 million into Wright Therapy Products, which developed a device for lymphedema patients. The Oakdale, Pa.-based company will use the money to advance product development and trials and commercialize its product. American City Business Journals/Pittsburgh/Financial District blog (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
5 positive ways to respond to negative comments.
Social media is a great way to connect with your customers, but what do you do when the conversation takes a negative turn? With 5 tips, you can learn how to positively respond and help direct the conversation. Read the article and learn the 5 ways to respond positively.

Business & Market Trends
Equity round brings in $3M for ForSight Vision6
ForSight Vision6, based in Menlo Park, Calif., has pulled in $3 million in an equity round with five undisclosed investors, according to a regulatory filing. The company was part of the ForSight Labs ophthalmology incubator, which also produced ForSight Vision5, the developer of the Helios ocular implant. MassDevice.com (Boston) (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
K2M Group plans to move headquarters to Va.
K2M Group is moving its headquarters and R&D facility to Leesburg, Va. The $28 million plan is expected to generate 97 new jobs and keep its current 268 jobs. St. Louis Post-Dispatch/The Associated Press (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
Orthopedic device company secures $575K
OrthogenRx, an orthopedic device company, has raised $575,000 in financing from Ben Franklin Technology Partners. The firm plans to use the funds on the development of new products and to finance applications for FDA product approval. BeckersSpine.com (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
International Developments
German firm Sygnis pulls in $6.2M in financing
Sygnis, the German developer of the TruePrime Single Cell WGA kit, has closed its rights offering and secured a total of $6.2 million. The firm will use the money to bring its products to the market, fund further product development and business operations. GenomeWeb Daily News (free registration) (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
SDRI enters European distribution deal with joimax
California-based joimax has agreed to to bring Synergy Disc Replacement's SYNERGY Cervical Disc to Germany, Austria and Switzerland under a five-year contract between the companies. SDRI also aims to receive U.S. approval for the cervical disc replacement device. BeckersSpine.com (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
Business Tips and Advice
Sponsored Links from American Express OPEN on openforum.com
Click here to learn more about Featured Content
Science & Health
Firm commences trial for staph ID/R test
Great Basin Scientific is beginning a trial for its staph identification/resistance molecular assay. The assay provides speciation of clinically critical Staphylococcus species, enabling the identification of environmental contaminants from infectious pathogens, the company said. The test, which generates results in less than two hours, requires hands-on time of less than two minutes. GenomeWeb Daily News (free registration) (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Technologies
New trial begins for Stimwave's chronic back pain device
A new randomized, placebo-controlled trial has been launched by Stimwave Technologies to test the use of its wireless neuromodulation device for treating chronic lower back pain. The double-blind study will measure the overall pain score of 45 patients using spinal nerve stimulation and a sham device. MassDevice.com (Boston) (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
Hot Topics
Government & Regulatory
Alere's rapid HIV test gains FDA waiver
Alere obtained a waiver from the FDA for the expanded use of its Determine HIV-1/2 Ag/Ab Combo test. The test, which was previously used only in licensed hospitals and laboratories, can now be utilized in locations such as physician's offices and clinics. FDAnews (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
FDA review may result in removal of devices from high-risk category
Some devices may be bumped off the highest-risk category after the FDA finishes the review of its premarket approval program, where it's studying the possibility of moving some premarket data to postmarket, said Bill Maisel, the deputy director for science at the agency's Center for Devices & Radiological Health. The review is expected to wrap up in 2015. MassDevice.com (Boston) (12/12)
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed News
PMA Submissions Workshop
Thursday, Feb. 26, to Friday, Feb. 27
Loews Madison Hotel, Washington, D.C.
Senior industry experts and members of the CDRH device evaluation and bioresearch monitoring staff (invited) will lead professionals through the strategic considerations and practical steps of filing a Premarket Approval. Topics to be discussed include the preparation needed for an adviser panel meeting, tips to prepare for an inspection, how to deal with unexpected clinical outcomes and more. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
See AdvaMed-MTLI's schedule of courses
Continue your professional development! See AdvaMed-MTLI's schedule of courses.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
Senior Analyst ComplianceEdwards LifesciencesIrvine, CA
Senior Manager, Clinical Affairs - Advanced TechnologyEdwards LifesciencesIrvine, CA
Click here to view more job listings.
Some of us think holding on makes us strong; but sometimes it is letting go."
-- Hermann Hesse,
German-Swiss writer and poet
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Lisa Gough
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:  Elizabeth Stack

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information